Cargando…
EP300 knockdown reduces cancer stem cell phenotype, tumor growth and metastasis in triple negative breast cancer
BACKGROUND: Triple negative breast cancer (TNBC) is an aggressive breast cancer subtype with basal features, lacking the expression of receptors targeted successfully in other breast cancer subtypes. Treatment response to adjuvant and neoadjuvant chemotherapy is often short-lived and metastatic spre...
Autores principales: | Ring, Alexander, Kaur, Pushpinder, Lang, Julie E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653866/ https://www.ncbi.nlm.nih.gov/pubmed/33167919 http://dx.doi.org/10.1186/s12885-020-07573-y |
Ejemplares similares
-
The activation of
EP300
by F11R leads to EMT and acts as a prognostic factor in triple‐negative breast cancers
por: Li, Chien‐Hsiu, et al.
Publicado: (2023) -
MiR-1976 knockdown promotes epithelial–mesenchymal transition and cancer stem cell properties inducing triple-negative breast cancer metastasis
por: Wang, Jingyi, et al.
Publicado: (2020) -
Knockdown of SPON2 inhibits the growth of triple-negative breast cancer
por: Hu, Xueyi, et al.
Publicado: (2023) -
AXL knockdown gene signature reveals a drug repurposing opportunity for a class of antipsychotics to reduce growth and metastasis of triple-negative breast cancer
por: Goyette, Marie-Anne, et al.
Publicado: (2019) -
Experimental analysis of bladder cancer-associated mutations in EP300 identifies EP300-R1627W as a driver mutation
por: Luo, Mayao, et al.
Publicado: (2023)